UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
September 21, 2004
Date of Report (date of earliest event reported)
BIOMERICA, INC.
---------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 0-8765 95-2645573
-------- ------ ----------
(State or Other (Commission (IRS Employee
Jurisdiction of File Number) Identification Number)
1533 Monrovia Avenue
Newport Beach, California 92663
(Address of Principal Executive Offices
Including Zip Code)
949-645-2111
------------
(Registrant's Telephone Number,
Including Area Code)
----------
(Former Name or Former Address if Changed
Since Last Report)
Item 5.02 (b). Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers
On September 21, 2004, the Company and Board Director, Dr. Robert
Orlando, mutually agreed that he will not stand for re-election this year when
his term expires November 19, 2004, due to Dr. Orlando's time constraints. Dr.
Orlando will assume the consulting position of Medical Director for Clinical
Scientific Affairs for the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOMERICA, INC.
Dated: September 24, 2004 By: /s/ Zackary S. Irani
Name: Zackary S. Irani
Title: Chief Executive Officer